Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.
Trial record 18 of 2865 for:    Neuroendocrine Neoplasm | Neuroendocrine Tumors

Bevacizumab in Combination With Temozolomide in Patients With Neuroendocrine Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00137774
Recruitment Status : Completed
First Posted : August 30, 2005
Last Update Posted : April 9, 2013
Sponsor:
Collaborators:
Massachusetts General Hospital
Beth Israel Deaconess Medical Center
Brigham and Women's Hospital
Genentech, Inc.
Schering-Plough
Information provided by (Responsible Party):
Matthew H. Kulke, MD, Dana-Farber Cancer Institute